NSC 3973
NSC 3973 Brand names, NSC 3973 Analogs
- (+)-Aspartic acid
- (2S)-Aspartic acid
- (L)-ASPARTIC ACID
- (S)-Aminobutanedioic acid
- (S)-Aspartic acid
- 4-04-00-02998 (Beilstein Handbook Reference)
- AI3-04461
- Acide aspartique [INN-French]
- Acido aspartico [INN-Spanish]
- Acidum asparticum
- Acidum asparticum [INN-Latin]
- Aminosuccinic acid
- Asparagic acid
- Asparagic acid (VAN)
- Asparaginic acid
- Asparaginic acid (VAN)
- Asparaginsaeure [German]
- Aspartate
- Aspartate, L-
- Aspartic Acid [USAN:INN]
- Aspartic acid
- Aspartic acid (VAN)
- Aspartic acid, L-
- Aspatofort
- BRN 1723530
- Butanedioic acid, amino-, (S)-
- CCRIs 6181
- EINECS 200-291-6
- FEMA No. 3565
- H-Asp-OH
- HSDB 1430
- L( )-Aminobernsteinsaeure
- L-(+)-Aspartic acid
- L-2-Aminobutanedioic acid
- L-Aminosuccinic acid
- L-Asparagic acid
- L-Asparaginic acid
- L-Asparaginsaeure
- L-Asparaginsyra
- L-Aspartic acid
- L-Aspartinsaeure
- NSC 3973
NSC 3973 Brand Names Mixture
- No information avaliable
NSC 3973 Chemical_Formula
C4H7N1O4
NSC 3973 RX_link
No information avaliable
NSC 3973 fda sheet
NSC 3973 msds (material safety sheet)
NSC 3973 Synthesis Reference
No information avaliable
NSC 3973 Molecular Weight
133.104 g/mol
NSC 3973 Melting Point
230 oC
NSC 3973 H2O Solubility
4.5 g/l
NSC 3973 State
Solid
NSC 3973 LogP
-0.67 +/- 0.36
NSC 3973 Dosage Forms
Capsules and powder
NSC 3973 Indication
There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.
NSC 3973 Pharmacology
L-aspartate is considered a non-essential amino acid, meaning that, under normal physiological conditions, sufficient amounts of the amino acid are synthesized in the body to meet the body's requirements. L-aspartate is formed by the transamination of the Krebs cycle intermediate oxaloacetate. The amino acid serves as a precursor for synthesis of proteins, oligopeptides, purines, pyrimidines, nucleic acids and L-arginine. L-aspartate is a glycogenic amino acid, and it can also promote energy production via its metabolism in the Krebs cycle. These latter activities were the rationale for the claim that supplemental aspartate has an anti-fatigue effect on skeletal muscle, a claim that was never confirmed.
NSC 3973 Absorption
Absorbed from the small intestine by an active transport process
NSC 3973 side effects and Toxicity
Mild gastrointestinal side effects including diarrhea. LD50 (rat) > 5,000 mg/kg.
NSC 3973 Patient Information
No information avaliable
NSC 3973 Organisms Affected
Humans and other mammals
